James H. Fleming

22 papers receiving 586 citations

James H. Fleming's Hit Papers

Empagliflozin in Heart Failure 2020 · 281 citations
2810+2+4Years since publication50100150200250

Peers

James H. Fleming
Comparison fields: 5 of 74
  • Nephrology 109
  • Endocrinology, Diabetes and Metabolism 202
  • Cardiology and Cardiovascular Medicine 158
  • Ecological Modeling 18
  • Pulmonary and Respiratory Medicine 119
Replace José Antonio Gimeno-Orna with:
José Antonio Gimeno-Orna Spain
Mustafa Akçakoyun Türkiye
Giorgio Colombo Italy
Christina Lindahl Sweden
J J Bending United Kingdom
Judita Knez Belgium
Kunshen Liu China
Jean‐Philippe Lengelé Belgium
Sonia Prince France
Malika Lajemi France
James H. Fleming relative to José Antonio Gimeno-Orna Spain José Antonio Gimeno-Orna's profile →
Citations per field
00.5×10×15×18×
José Antonio Gimeno-Orna · 1×
Citations per year

Countries citing papers authored by James H. Fleming

Since Specialization
Citations

This map shows the geographic impact of James H. Fleming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James H. Fleming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James H. Fleming more than expected).

Fields of papers citing papers by James H. Fleming

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James H. Fleming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James H. Fleming. The network helps show where James H. Fleming may publish in the future.

Co-authors

The 25 scholars most cited alongside James H. Fleming, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with James H. Fleming Line = papers co-authored together James H. Fleming links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Empagliflozin in Heart Failure
Hit paper breakdown →
2020281
2 2005116
3 202142
4 201233
5 202027
6 201918
7 202017
8 202012
9 196311
10 198810
11 20209
12 19776
13 20064
14 20234
15 20194
16 20202
17 20192
18 20202
19 20202
20 19711

About James H. Fleming

James H. Fleming is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Nephrology, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine, having authored 25 papers that have together received 605 indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (6 papers), Hemodynamic Monitoring and Therapy (4 papers), Diabetes Treatment and Management (3 papers), Blood Pressure and Hypertension Studies (2 papers), Electrolyte and hormonal disorders (2 papers), Nutrition and Health in Aging (2 papers), Dialysis and Renal Disease Management (2 papers) and Muscle metabolism and nutrition (1 paper). The work is most often cited by research in Nephrology (109 citations), Endocrinology, Diabetes and Metabolism (202 citations), Cardiology and Cardiovascular Medicine (158 citations), Ecological Modeling (18 citations) and Pulmonary and Respiratory Medicine (119 citations). James H. Fleming has collaborated with scholars based in United States, Mexico and Brazil. Frequent co-authors include Matthew D. Griffin, Jeffrey M. Testani, Veena S. Rao, Juan B. Ivey‐Miranda, Devin Mahoney, Zachary L. Cox, Jeffrey M. Turner, Sean P. Collins, Christopher Maulion and F. Perry Wilson. Their work appears in journals such as Journal of Cardiac Failure, Journal of the American College of Cardiology, ESC Heart Failure, Biodiversity and Conservation and Journal of the Royal Society of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact